Patent Yard Sign in
Expired European patentEurope

Method to distinguish prostate cancer from benign prostatic hyperplasia

EP 1175619 B1 · Applicant: HYBRITECH INCORPORATED

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Google PatentsEPO PDF

Why it's free to use

  • Filed April 12, 2000 and granted November 2, 2005. A European patent lasts at most 20 years from filing, so its term ended April 12, 2020.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by October 12, 2025.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledApril 12, 2000
PublishedJanuary 30, 2002
GrantedNovember 2, 2005
Term endedApril 12, 2020
Application numberEP 00922118
Classification (CPC)G01N33/57555

Timeline

Timeline From EPO dates

2001200320052007200920112013201520172019Application filedApril 12, 2000PublishedJan 30, 2002Patent grantedNov 2, 2005Term endedApril 12, 2020

Sources & verification

Official EPO records

Full published documentClaims, description and drawings as a PDF.EPOEuropean Patent RegisterProcedure, status, file inspection and legal events.EPOLinked open EP data recordThe bibliographic record this page is built from.EPO

Cross-check elsewhere

Google PatentsFull text, worldwide family, citing patents and legal events.patents.google.comEspacenetNational family members and their legal status.European Patent Office

Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.